PP
VanEck Pharmaceutical ETF (PPH)
NASDAQ
116.51
-0.12 (-0.10%)
Closed
Aug 24, 2026
Day's Range
115.50116.55
52 wk Range
85.91117.73
Overview - PPH - VanEck Pharmaceutical ETF
Key Statistics
Valuation
P/E (Trailing)
‪25.82‬
Price stats
50-Day Avg
‪109.62‬
200-Day Avg
‪105.10‬
Dividends
Frequency
Quarterly
Market Cap - PPH - VanEck Pharmaceutical ETF
Peers - PPH - VanEck Pharmaceutical ETF
Peer Comparison
Compared with other ETFs.
- PPPPHNASDAQVanEck Pharmaceutical ETF1.14BMarket Cap+24.63%52-week change25.83P/E (Trailing)—Profit Margin
- DVYNASDAQiShares Select Dividend ETF26.67BMarket Cap+13.96%52-week change16.15P/E (Trailing)—Profit Margin
- DUDUKHNASDAQOcean Park High Income ETF16.90BMarket Cap-2.85%52-week change15.66P/E (Trailing)—Profit Margin
- CSBNASDAQVictoryShares US Small Cap High Div Volatility Wtd ETF13.02BMarket Cap+11.66%52-week change14.94P/E (Trailing)—Profit Margin
- CSCSBIXNASDAQCromwell Balanced Fund Institutional Class6.82BMarket Cap+0.00%52-week change24.96P/E (Trailing)—Profit Margin
- CALYNASDAQBlackRock Short-Term California Muni Bond ETF2.83BMarket Cap+39.08%52-week change36.95P/E (Trailing)‪-12.36%‬Profit Margin
- DVGRNASDAQDAC 3D Dividend Growth ETF1.40BMarket Cap+8.20%52-week change24.20P/E (Trailing)‪19.40%‬Profit Margin
Profile Summary - PPH - VanEck Pharmaceutical ETF
About
The VanEck Pharmaceutical ETF is an exchange-traded fund that primarily focuses on tracking the performance of global pharmaceutical companies. Its main purpose is to offer investors exposure to a diversified portfolio of firms within the pharmaceutical sector. This ETF encompasses a range of large-scale and…
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
